Adverse Reactions to Biologics (Current Problems in Dermatology, Vol. 53)

In the fast-evolving world of medicine, physicians face complex challenges when it comes to finding therapies that will meet the needs of their patients. In dermatology, several significant advances have been made recently in the understanding of inflammatory and malignant cutaneous disorders. These breakthroughs, combined with significant developments in targeted immunotherapy, are leading to improved outcomes for patients with chronic inflammatory skin disorders and various forms of skin cancer. The newly published book, “Targeted Therapy in Dermatology,” aims to provide insights into the latest developments in this field.

Edited by L. Puig, W. Gulliver, P. Itin, and G.B.E. Jemec, “Targeted Therapy in Dermatology” offers a comprehensive overview of the safety and efficacy of targeted therapies. The authors are eminent researchers with clinical experience who have contributed significantly to the understanding of this complex field.

The book features a range of topics, including adverse reactions, infectious complications, and the perioperative use of biologics in psoriasis. It also covers immunogenicity of biologic therapies, paradoxical reactions, and safety of biologics used to treat autoimmune bullous diseases and primary cutaneous lymphomas. Additionally, the book includes information on adverse reactions and skin manifestations of therapies targeting melanoma, non-melanoma skin cancer, and other neoplastic diseases.

One of the key strengths of the book is its focus on safety. In recent years, the use of targeted therapies has been associated with an increased risk of adverse events. By understanding the safety profile of these therapies, physicians can make more informed treatment decisions that ultimately improve patient outcomes.

The book is the 53rd volume in the “Current Problems in Dermatology” series, published by S. Karger. It is available as a digital eBook and has 108 pages. It was published in November 2017 in English and has ISBN-10 331806100X and ISBN-13 978-3318061000.

The authors approach the subject matter in a systematic and organized manner. Each topic is carefully researched, and the information is presented in a clear and concise manner. Additionally, the book is thoroughly referenced, providing readers with a wealth of additional resources to explore the topic further.

The style of the writing is technical yet easy to understand for readers with a background in dermatology. The book is an excellent resource for dermatologists, oncologists, and other healthcare professionals who treat patients with skin disorders. Additionally, it is an excellent read for researchers and students interested in this field.

For those who are interested in this subject matter, “Targeted Therapy in Dermatology” is a must-read. It provides a comprehensive overview of the latest advances in this field and is a valuable resource for anyone looking to expand their knowledge of targeted therapies. Ordering this book will not only provide you with valuable insights and knowledge, but it will also contribute to the advancement of dermatology research. So, order your copy today and be at the forefront of this exciting field of medicine.

Product Details

• Series: Current Problems in Dermatology, Vol. 53 (Book 53)
• Hardcover: 108 pages
• Publisher: S. Karger; 1 edition (November 30, 2017)
• Language: English
• ISBN-10: 331806100X
• ISBN-13: 978-3318061000